Article Sidebar
Article Details
Issue
Section
Articles
Material submitted for publication in the South African Journal of Bioethics and Law (SAJBL) is accepted provided it has not been published elsewhere. The SAJBL reserves copyright of the material published.
The SAJBL does not hold itself responsible for statements made by the authors.
Main Article Content
Compensation for research-related injury in South Africa: A critique of the good clinical practice (GCP) guidelines
Abstract
This article examines the current South African Department of Health Good Clinical Practice (2006) guideline recommendations regarding compensation for harm incurred in clinical trials. It applies the case of a phase IIb HIV vaccine trial in South Africa, for which enrolments and vaccinations were suspended early, based on data from an international companion study that indicated no evidence of efficacy and greater susceptibility to HIV infection in a subgroup of vaccinees. The case application indicates certain substantive and procedural limitations within the South African Department of Health Good Clinical Practice (2006) guideline recommendations on compensation for harm, which should be re-considered in order to improve protections for trial participants.
